These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9207914)

  • 1. Synthesis and structure-activity relationships of a novel oral carbapenem, CS-834.
    Miyauchi M; Endo R; Hisaoka M; Yasuda H; Kawamoto I
    J Antibiot (Tokyo); 1997 May; 50(5):429-39. PubMed ID: 9207914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of a 1beta-methylcarbapenem antibiotic, pivaloyloxymethyl (1R,5S,6S)-6-[(R)-1-hydroxyethyl]-1-methyl-2-[[(R)-5-oxopyrrolidin-3-yl]thio]-1-carbapen-2-em-3-carboxylate, CS-834 dihydrate.
    Kobayashi K; Fukuhara H; Kawamoto I; Ito S; Hata T
    Anal Sci; 2001 Feb; 17(2):357-8. PubMed ID: 11990557
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis and structure-activity relationships of novel parenteral carbapenems, CS-023 (R-115685) and related compounds containing an amidine moiety.
    Kawamoto I; Shimoji Y; Kanno O; Kojima K; Ishikawa K; Matsuyama E; Ashida Y; Shibayama T; Fukuoka T; Ohya S
    J Antibiot (Tokyo); 2003 Jun; 56(6):565-79. PubMed ID: 12931867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the synthesis and structure-activity relationships of 2-(2-functionalized pyrrolidin-4-ylthio)-1 beta-methylcarbapenems.
    Lee HW; Kim EN; Son HJ; Ahn SK; Chung KH; Kim JW; Lee CR
    Chem Pharm Bull (Tokyo); 1996 Dec; 44(12):2326-30. PubMed ID: 8996864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel 1 beta-methylcarbapenem antibiotic, S-4661. Synthesis and structure-activity relationships of 2-(5-substituted pyrrolidin-3-ylthio)-1 beta-methylcarbapenems.
    Iso Y; Irie T; Nishino Y; Motokawa K; Nishitani Y
    J Antibiot (Tokyo); 1996 Feb; 49(2):199-209. PubMed ID: 8621362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syntheses and pharmacokinetic studies of prodrug esters for the development of oral carbapenem, L-084.
    Isoda T; Ushirogochi H; Satoh K; Takasaki T; Yamamura I; Sato C; Mihira A; Abe T; Tamai S; Yamamoto S; Kumagai T; Nagao Y
    J Antibiot (Tokyo); 2006 Apr; 59(4):241-7. PubMed ID: 16830892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of new oral carbapenems with 1-methyl-5-oxopyrrolidin-3-ylthio moiety.
    Kanno O; Miyauchi M; Shibayama T; Ohya S; Kawamoto I
    J Antibiot (Tokyo); 1999 Oct; 52(10):900-7. PubMed ID: 10604760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel C-2 substituted carbapenem derivatives. Part II. Synthesis and structure-activity relationships of isoxazolin-2-yl, isoxazolidin-2-yl and 2-pyrazolin-2-yl carbapenems generated using 1,3-dipolar cycloaddition chemistry.
    Burton G; Clarke GJ; Douglas JD; Eglington AJ; Frydrych CH; Hinks JD; Hird NW; Hunt E; Moss SF; Naylor A; Nicholson NH; Pearson MJ
    J Antibiot (Tokyo); 1996 Dec; 49(12):1266-74. PubMed ID: 9031673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel C-2 substituted carbapenem derivatives. Part IV. Synthesis and biological activity of five membered heteroaromatic derivatives.
    Branch CL; Burton G; Clarke GJ; Coulton S; Douglas JD; Eglington AJ; Guest AW; Hinks JD; Hird NW; Holland RK; Hunt E; Knott SJ; Moss SF; Naylor A; Pearson MJ; Takle AK
    J Antibiot (Tokyo); 1998 Feb; 51(2):210-20. PubMed ID: 9544943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CP0569, a new broad-spectrum injectable carbapenem. Part 1: synthesis and structure-activity relationships.
    Aihara K; Kano Y; Shiokawa S; Sasaki T; Setsu F; Sambongi Y; Ishii M; Tohyama K; Ida T; Tamura A; Atsumi K; Iwamatsu K
    Bioorg Med Chem; 2003 Aug; 11(16):3475-85. PubMed ID: 12878141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel carbapenem antibiotic, SM-7338 structure-activity relationships.
    Sunagawa M; Matsumura H; Inoue T; Fukasawa M; Kato M
    J Antibiot (Tokyo); 1990 May; 43(5):519-32. PubMed ID: 2358404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heteroaryliumthio substituted carbapenem derivatives: synthesis and in vitro activity of 1 beta-methyl-2-(dihydropyrrolotriazoliumthio)carbapenems.
    Wildonger KJ; Ratcliffe RW
    J Antibiot (Tokyo); 1993 Dec; 46(12):1866-82. PubMed ID: 8294246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and in vitro activity of a series 1beta-methylcarbapenem derivatives.
    Jeon HC; Kim JW; Hong JH; Cho JH; Oh CH
    Eur J Med Chem; 2006 Oct; 41(10):1201-9. PubMed ID: 16797791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antibacterial activity of 1 beta-methyl-2-(5-substituted imidazolino pyrrolidin-3-ylthio)carbapenem derivatives.
    Oh CH; Lee CS; Lee JS; Cho JH
    Arch Pharm (Weinheim); 2003 Nov; 336(11):504-9. PubMed ID: 14639742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and structure-activity relationships of 1beta-methylcarbapenems with quaternary ammonium side chains.
    Ishikawa K; Kojima K; Miyauchi M; Endo R; Yasuda H; Kawamoto I
    J Antibiot (Tokyo); 1998 Aug; 51(8):757-70. PubMed ID: 9766468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CW-270033, a novel pyrrolidinyl-thio carbapenem, has potent antimicrobial activity in vitro and in vivo.
    Kim J; Ha JR; Oh SW; Kim HG; Lee JM; Lee DG; Lee SH; Kim JG
    Biol Pharm Bull; 2007 Mar; 30(3):575-9. PubMed ID: 17329859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo antibacterial activities of CS-834, a new oral carbapenem.
    Yamaguchi K; Domon H; Miyazaki S; Tateda K; Ohno A; Ishii K; Matsumoto T; Furuya N
    Antimicrob Agents Chemother; 1998 Mar; 42(3):555-63. PubMed ID: 9517932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1 beta-Methyl-2-(5-substituted pyrrolidin-3-ylthio)carbapenems. 3. Synthesis and antibacterial activity of BO-2727 and its related compounds.
    Ohtake N; Okamoto O; Mitomo R; Kato Y; Yamamoto K; Haga Y; Fukatsu H; Nakagawa S
    J Antibiot (Tokyo); 1997 Jul; 50(7):598-613. PubMed ID: 9711251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and properties of 2-(naphthosultamyl)methyl-carbapenems with potent anti-MRSA activity: discovery of L-786,392.
    Ratcliffe RW; Wilkening RR; Wildonger KJ; Waddell ST; Santorelli GM; Parker DL; Morgan JD; Blizzard TA; Hammond ML; Heck JV; Huber J; Kohler J; Dorso KL; St Rose E; Sundelof JG; May WJ; Hammond GG
    Bioorg Med Chem Lett; 1999 Mar; 9(5):679-84. PubMed ID: 10201828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antibacterial activity of 1beta-methyl-2-(5-substituted oxadiazolo pyrrolidin-3-yl-thio)carbapenem derivatives.
    Oh CH; Dong HG; Lee JS; Lee SC; Hong JH; Cho JH
    Arch Pharm (Weinheim); 2003 Dec; 336(12):567-72. PubMed ID: 14677150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.